Evidence map›Paper›PMID 37249012›Full record

ArticleEMBO reports2023

Ovol1/2 loss-induced epidermal defects elicit skin immune activation and alter global metabolism.

Morgan Dragan, Zeyu Chen, Yumei Li, Johnny Le, Peng Sun, Daniel Haensel, Suhas Sureshchandra, Anh Pham, Eddie Lu, Katherine Thanh Pham and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fine-mapping causal tissues and genes at disease-associated loci.medRxiv : the preprint server for health sciences · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Morgan DraganDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0002-6401-6816
Zeyu ChenDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Yumei LiDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0003-3538-6268
Johnny LeDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0002-0245-5848
Peng SunDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Daniel HaenselDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0001-5168-4068
Suhas SureshchandraDepartment of Physiology and Biophysics, School of Medicine, University of California, Irvine, CA, USA.
Anh PhamDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0002-4689-6688
Eddie LuDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Katherine Thanh PhamDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Amandine VerlandeDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0001-6794-4119
Remy VuDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Guadalupe GutierrezDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Wei LiDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Cholsoon JangDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Selma MasriDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Xing DaiDepartment of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.ORCID 0000-0001-8134-1365
University of California, Irvine · US

Funding

UCI P30 Skin Center Systems Biology CoreP30AR075047 · NIAMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI ANDERSEN, BOGI, GANESAN, ANAND K · 2019 to 2025
$5.1M
Multiscale Models of Wound Cell Plasticity for RegenerationU01AR073159 · NIAMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAI, XING, NIE, QING · 2018 to 2022
$3.5M
Circadian Clock and Myc-dependent Regulation of Cellular TransformationR01CA259370 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Selma Masri · 2022 to 2026
$3.0M
Circadian Clock Disruption and Colorectal CancerR01CA244519 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Selma Masri · 2020 to 2026
$3.0M
Intrinsic and extrinsic control of epithelial tissue stem cell activityR35GM145307 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Xing Dai · 2022 to 2026
$2.2M
Elucidating dietary fructose and alcohol interactions during liver cancer developmentR01AA029124 · NIAAA · UNIVERSITY OF CALIFORNIA-IRVINE · PI JANG, CHOLSOON · 2021 to 2025
$2.0M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
Mammary basal/stem cell plasticity and regulationR01GM123731 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAI, XING · 2017 to 2020
$1.9M
Control of epithelial plasticity and differentiation in hair follicle stem/progenitor cellsR01AR068074 · NIAMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI DAI, XING · 2015 to 2019
$1.7M
NCI NIH HHS R01 CA244519NCI NIH HHS R01 CA259370NIAAA NIH HHS R01 AA029124NIAID NIH HHS T32 AI060573NIAMS NIH HHS P30 AR075047NIAMS NIH HHS R01 AR068074NIAMS NIH HHS U01 AR073159NIGMS NIH HHS R01 GM123731NIGMS NIH HHS R35 GM145307
6 · The paper itself

Abstract

Skin epidermis constitutes the outer permeability barrier that protects the body from dehydration, heat loss, and myriad external assaults. Mechanisms that maintain barrier integrity in constantly challenged adult skin and how epidermal dysregulation shapes the local immune microenvironment and whole-body metabolism remain poorly understood. Here, we demonstrate that inducible and simultaneous ablation of transcription factor-encoding Ovol1 and Ovol2 in adult epidermis results in barrier dysregulation through impacting epithelial-mesenchymal plasticity and inflammatory gene expression. We find that aberrant skin immune activation then ensues, featuring Langerhans cell mobilization and T cell responses, and leading to elevated levels of secreted inflammatory factors in circulation. Finally, we identify failure to gain body weight and accumulate body fat as long-term consequences of epidermal-specific Ovol1/2 loss and show that these global metabolic changes along with the skin barrier/immune defects are partially rescued by immunosuppressant dexamethasone. Collectively, our study reveals key regulators of adult barrier maintenance and suggests a causal connection between epidermal dysregulation and whole-body metabolism that is in part mediated through aberrant immune activation.

Indexed as

DNA-Binding ProteinsEpidermisEpidermal CellsSkinTranscription FactorsDNA-Binding ProteinsTranscription Factorsepidermisepithelial-mesenchymal plasticity (EMP)immunemetabolismOvol1/Ovol2

Identifiers

PMID37249012
PMCPMC10328084
OpenAlexW4378746761

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.